SWEAT (SWEAT) 24-hour volatility reaches 848.5%: Low liquidity trading volume surges more than 10 times, triggering FOMO pump
Bitget Pulse2026/05/10 16:02Volatility Overview
Over the past 24 hours, the price of SWEAT surged from a low of $0.0004217 to a high of $0.004, currently quoted at $0.00226, with an amplitude as high as 848.5%. Trading volume skyrocketed to approximately $25-30 million, an increase of over 600%-800% compared to the previous day, accounting for more than 100% of the market cap, mainly concentrated in trading pairs such as Kraken (SWEAT/USD), Bitvavo (SWEAT/EUR), and Bitget (SWEAT/USDT).
Brief Analysis of Abnormal Movements
• Sudden surge in trading volume on low-liquidity pairs, increasing more than 10 times, directly pushed the price from a low of $0.0001847 to a high of $0.004, triggering a FOMO rally effect.
• No official announcements, on-chain whale transfers, or recorded news events; mainly retail investors heavily involved and long liquidations (short positions exceeding $20 million across the market), amplifying volatility.
Market Opinions & Outlook
The main sentiment in the community is excitement. Multiple posts on X platform state “rocketed +293%” or “surged 89.8% in 1h”, viewing it as “explosive momentum” and expecting support to hold at $0.0018-0.002; however, analysts remind of the high volatility risk, suggest waiting for a pullback to enter, and note that the low market cap (about $24 million) is vulnerable to selling pressure, so the market may continue to fluctuate.
Note: This analysis is automatically generated by AI based on public data and on-chain monitoring, for informational purposes only.Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
Marvell Technology (MRVL.US) plummets after earnings: Beating forecasts is not enough—Wall Street thinks Google (GOOGL.US) orders are recognized too slowly
Although Marvell Technology's latest financial report and future revenue guidance both superficially exceeded market expectations, its stock price still plummeted in pre-market trading on Friday.

Gold prices could soar to $12,000 if US national debt keeps rising, says strategist
PURR stock hits record $14.15 as Hyperliquid revenue tops $718 million
From Lowering Blood Sugar and Weight Loss to Cardiovascular Protection! Mounjaro Achieves "Cardiometabolic Leap," Lilly (LLY.US) Opens GLP-1's Second Growth Curve
Eli Lilly's diabetes drug Mounjaro has received approval in the United States for reducing the risk of serious cardiovascular disease. The U.S. Food and Drug Administration has approved Mounjaro for lowering cardiovascular risk in adults with type 2 diabetes who have established heart disease.
